Skip to content

A Multi-centre, Prospective Observational Study comparing Supervised Personal versus In-Lab Spirometry in Adults and Children with a Chronic Lung Disease

A Multi-centre, Prospective Observational Study comparing Supervised Personal versus In-Lab Spirometry in Adults and Children with a Chronic Lung Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12623000288628
Enrollment
150
Registered
2023-03-17
Start date
2024-02-21
Completion date
2024-02-21
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To determine if supervised home spirometry can replace in-lab spirometry when needed, this study will evaluate Australian Register of Therapeutic Goods (ARTG) approved home spirometry quantitative and qualitative performance compared with in-lab spirometry supervised by a respiratory scientist. Older spirometers (> 1 year of use) will have a calibration check to assess ongoing validity of results. Hypothesis: a) Supervised outpatient spirometry indices (FEV1, FVC) and grade performed on a personal portable spirometer via Telehealth and standard in-lab spirometry 15 minutes apart in patients with chronic lung disease will be comparable b) Home spirometers will remain reliable after > 1 year of use

Interventions

This prospective observational study will compare objective spirometer indices (FEV1, FVC) and grade with portable personal spirometers via Telehealth and in-lab spirometry in an outpatient setting. This will occur at the patient’s routine clinic appointment, where they will be advised to bring in their own home spirometer. This initiative will be part of each laboratory’s quality control practice. Only TGA approved portable home spirometers will be included in this study. Participants will only

This prospective observational study will compare objective spirometer indices (FEV1, FVC) and grade with portable personal spirometers via Telehealth and in-lab spirometry in an outpatient setting. This will occur at the patient’s routine clinic appointment, where they will be advised to bring in their own home spirometer. This initiative will be part of each laboratory’s quality control practice. Only TGA approved portable home spirometers will be included in this study. Participants will only need to partake in testing and device calibration once. This will all occur during the same face to face visit. No additional assessments will be required after that. Patients who meet the inclusion and exclusion criteria will be invited to participate in the study, and will use their existing personal home spirometer. Consent will be obtained from all patients/guardian where applicable. Respiratory scientists will perform a portable spirometer calibration check will prior to the participant performing spirometry on the device. Patients will then perform in-lab or portable pre-bronchodilator home spirometry via Telehealth in random order, supervised by a respiratory scientist in an accredited respiratory function laboratory equipped to perform complex lung function in either the paediatric or adult setting. To mimic the telehealth mode of home spirometry and still allow for testing of devices within 15 minutes of each other, spirometry via Telehealth will be performed with the patient in their clinic room during their outpatient hospital visit and the respiratory scientist supervising spirometry from a different location in the hospital. An additional 15-20 minutes is anticipated to be required to complete spirometry using both in-lab and portable spirometry. Respiratory scientists will ensure that a standardized approach to performing spirometry as per the American Thoracic Society/European Respiratory Society Technical Statement will be undertaken for both in-lab and spirometry via telehealth. Testing will occur in a quiet and comfortable environment that is separated from the waiting room and other patients being tested. The patient should be seated erect, with shoulders slightly back and chin slightly elevated. A smaller chair or a raised footstool may be required for children and small adults.

Sponsors

Royal Prince Alfred Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Children and adults felt to be capable of performing spirometry with an Australian Register of Therapeutic Goods (ARTG) approved home spirometer and a chronic lung disease requiring regular formal spirometry.

Exclusion criteria

a) No TGA approved home spirometer b) Behavioural or cognitive disabilities precluding the individual’s ability to perform spirometry

Outcome results

None listed

Source: ANZCTR · Data processed: Jul 23, 2026